Impact of Public Comments on Prescription Drug Benefits in Essential Health Benefits Final Ruling
Track
:
Professional Poster Session, Tuesday, June 25, 2013
Program Code:
T19
SPEAKER
:
Justin Balint, PharmD (SPKSUP), Post-Doctoral Fellow, Oncology Advocacy and Policy, Rutgers, The State University of New Jersey, United States
Justin J Balint is a Fellow with the Rutgers Institute for Pharmaceutical Industry Fellowship, where he is currently entering his second year as an Oncology Advocacy and Policy Fellow with Bristol-Myers Squibb. He received his PharmD from Wilkes University in 2012.